GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » Cyclically Adjusted PB Ratio

BGI Genomics Co (SZSE:300676) Cyclically Adjusted PB Ratio : 3.09 (As of Jun. 05, 2025)


View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co Cyclically Adjusted PB Ratio?

As of today (2025-06-05), BGI Genomics Co's current share price is ¥52.30. BGI Genomics Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ¥16.91. BGI Genomics Co's Cyclically Adjusted PB Ratio for today is 3.09.

The historical rank and industry rank for BGI Genomics Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:300676' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.35   Med: 2.91   Max: 3.96
Current: 3.04

During the past years, BGI Genomics Co's highest Cyclically Adjusted PB Ratio was 3.96. The lowest was 2.35. And the median was 2.91.

SZSE:300676's Cyclically Adjusted PB Ratio is ranked worse than
67.39% of 138 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.875 vs SZSE:300676: 3.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BGI Genomics Co's adjusted book value per share data for the three months ended in Mar. 2025 was ¥21.886. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥16.91 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


BGI Genomics Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BGI Genomics Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGI Genomics Co Cyclically Adjusted PB Ratio Chart

BGI Genomics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.55

BGI Genomics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.96 2.55 3.11

Competitive Comparison of BGI Genomics Co's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, BGI Genomics Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BGI Genomics Co's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BGI Genomics Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BGI Genomics Co's Cyclically Adjusted PB Ratio falls into.


;
;

BGI Genomics Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BGI Genomics Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=52.30/16.91
=3.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGI Genomics Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, BGI Genomics Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=21.886/115.1156*115.1156
=21.886

Current CPI (Mar. 2025) = 115.1156.

BGI Genomics Co Quarterly Data

Book Value per Share CPI Adj_Book
201412 4.639 99.000 5.394
201506 9.196 99.500 10.639
201512 8.597 100.600 9.837
201603 0.000 102.200 0.000
201606 0.000 101.400 0.000
201609 0.000 102.400 0.000
201612 9.333 102.600 10.471
201703 9.295 103.200 10.368
201706 9.560 103.100 10.674
201709 10.108 104.100 11.178
201712 10.369 104.500 11.422
201803 10.544 105.300 11.527
201806 10.577 104.900 11.607
201809 10.722 106.600 11.579
201812 10.125 106.500 10.944
201903 10.619 107.700 11.350
201906 10.748 107.700 11.488
201909 11.149 109.800 11.689
201912 10.915 111.200 11.299
202003 11.159 112.300 11.439
202006 13.952 110.400 14.548
202009 16.871 111.700 17.387
202012 14.772 111.500 15.251
202103 20.406 112.662 20.851
202106 21.886 111.769 22.541
202109 22.358 112.215 22.936
202112 22.513 113.108 22.913
202203 22.477 114.335 22.631
202206 23.563 114.558 23.678
202209 24.049 115.339 24.002
202212 24.344 115.116 24.344
202303 24.356 115.116 24.356
202306 23.966 114.558 24.083
202309 24.032 115.339 23.986
202312 23.820 114.781 23.889
202403 23.918 115.227 23.895
202406 24.143 114.781 24.213
202409 23.635 115.785 23.498
202412 21.968 114.893 22.011
202503 21.886 115.116 21.886

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BGI Genomics Co  (SZSE:300676) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BGI Genomics Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BGI Genomics Co Business Description

Traded in Other Exchanges
N/A
Address
21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083
BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.
Executives
Xu Qian Secretary Dong
Zhao Li Jian Directors, executives
Wang Yu Jue Directors, executives
Wang Jian Director
Liu Na Executives
Sun Ying Jun Director
Yin Ye Directors, executives
Du Yu Tao Directors, executives
Li Song Gang Supervisors
Hu Yu Jie Supervisors
Li Zhi Ping Executives
Chen Yi Qing Executives
Li Wen Qi Supervisors

BGI Genomics Co Headlines

No Headlines